X4 Pharmaceuticals, Inc.
Methods for treating immunodeficiency disease
Last updated:
Abstract:
The present invention relates to methods of treating patients with WHIM syndrome or related disorders, such as myelokathexis, in which X4P-001 is administered in order to reduce the activity of CXCR4. The methods demonstrate surprising effectiveness, with comparatively little toxicity.
Status:
Grant
Type:
Utility
Filling date:
28 Feb 2020
Issue date:
11 Jan 2022